受强制性开放获取政策约束的文章 - Martin Bergstrand了解详情
可在其他位置公开访问的文章：6 篇
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention
M Bergstrand, F Nosten, KM Lwin, MO Karlsson, NJ White, J Tarning
Science translational medicine 6 (260), 260ra147-260ra147, 2014
强制性开放获取政策： Swedish Research Council, Wellcome Trust
Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine
J Permala, J Tarning, F Nosten, NJ White, MO Karlsson, M Bergstrand
Antimicrobial Agents and Chemotherapy 61 (5), 10.1128/aac. 02491-16, 2017
强制性开放获取政策： Wellcome Trust
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
JP Lohy Das, MP Kyaw, MH Nyunt, K Chit, KH Aye, MM Aye, MO Karlsson, ...
Malaria Journal 17, 1-10, 2018
强制性开放获取政策： Bill & Melinda Gates Foundation, Wellcome Trust
Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
J Lohy Das, AM Dondorp, F Nosten, AP Phyo, W Hanpithakpong, ...
The AAPS Journal 19, 1842-1854, 2017
强制性开放获取政策： Bill & Melinda Gates Foundation, Wellcome Trust
External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients
D Rekić, D Röshammar, M Bergstrand, J Tarning, A Calcagno, A D’Avolio, ...
The AAPS journal 15, 308-315, 2013
强制性开放获取政策： Swedish Research Council, Wellcome Trust
Population Pharmacokinetic and Pharmacodynamic Properties of Artesunate in Patients with Artemisinin Resistant Infections in Southern Myanmar
J Lohy Das, MP Kyaw, M Nyunt, K Chit, K Aye, M Aye, MO Karlsson, ...
Malaria Journal 17, 2018
强制性开放获取政策： Bill & Melinda Gates Foundation, Wellcome Trust
出版信息和资助信息由计算机程序自动确定